Home > Insider Trading > Filing (0001415889-23-004626)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708527	Aziyo Biologics Inc.	AZYO	Biological Products, (No Disgnostic Substances) (2836)	474790334

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1825799	Thomas Englese	C/O Aziyo Biologics, Inc. 12510 Prosperity Drive, Suite 370 Silver Spring MD 20904	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2023-03-08	937	$0.00	18,206	No	4	M	Direct
Class A Common Stock	Disposition	2023-03-09	289	$4.30	17,917	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Units	Disposition	2023-03-08	937	$0.00	937	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,875			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").
Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.